Teva-CEO-Erez-Vigodman - MONTCO.Today
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Teva Execs Topped TASE's High Earners List for 2018 | Ctech
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva CEO: We have to launch new products - Globes
Teva CEO Erez Vigodman Steps Down | CHEManager
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Teva looks to amp up research collaborations, CEO says
Teva CEO: 'Content' With 2/3 Access of Payers for Migraine Drug Ajovy
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceutical CEO Talks Opioids, Lawsuits, and the Long Road Ahead | Barron's
Teva chooses new CEO
23 Teva Pharmaceuticals Open New Logistic Centre In Israel Photos and Premium High Res Pictures - Getty Images
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
Teva CEO reportedly wanted to stay in his job | The Times of Israel
In letter to Israeli PM, Teva CEO apologizes for drug-maker's sorry state | The Times of Israel
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
Teva Pharmaceuticals on Twitter: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the
Teva CEO Exits Amid Crisis of Confidence at Drugmaker
Schultz kept Teva away from the abyss, but couldn't find a runway to growth | Ctech
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
teva ceo News and latest stories | The Jerusalem Post
Erez Vigodman steps down as Teva CEO
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
